Cargando…

Modeling the Impact of Antiretroviral Use in Developing Countries

Bertozzi and Bautista-Arredondo discuss the implications of a new PLoS Medicine study that models the impact of antiretroviral drugs upon HIV transmission in developing countries.

Detalles Bibliográficos
Autores principales:	Bertozzi, Stefano M, Bautista-Arredondo, Sergio
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395348/ https://www.ncbi.nlm.nih.gov/pubmed/16522134 http://dx.doi.org/10.1371/journal.pmed.0030148

Ejemplares similares

The epidemiological impact of antiretroviral use predicted by mathematical models: a review
por: Baggaley, Rebecca F, et al.
Publicado: (2005)

Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
por: Ford, Nathan, et al.
Publicado: (2013)

Development of a public health emergency preparedness competency model for European Union countries
por: Stoto, Michael A., et al.
Publicado: (2018)

Impact of Antiretroviral Therapy on Intestinal Lymphoid Tissues in HIV Infection
por: Veazey, Ronald S, et al.
Publicado: (2006)

Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?
por: Caro-Vega, Yanink, et al.
Publicado: (2013)

Factors influencing global antiretroviral procurement prices
por: Wirtz, Veronika J, et al.
Publicado: (2009)

Antiretroviral Therapy for Prevention of HIV Infection: New Clues From an Animal Model
por: Cohen, Myron S, et al.
Publicado: (2008)

Designing an Equitable Strategy for Allocating Antiretroviral Treatments
por: Capron, Alexander M, et al.
Publicado: (2005)

Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
por: Mallon, Patrick W. G
Publicado: (2006)

Utilization and Monetization of Healthcare Data in Developing Countries
por: Bram, Joshua T., et al.
Publicado: (2015)

Climate Change and Aging Health in Developing Countries
por: Sarkar, Sabrina Maria, et al.
Publicado: (2023)

Factors facilitating sustainable scientific partnerships between developed and developing countries
por: Kunert, Karl J, et al.
Publicado: (2020)

Is Antiretroviral Therapy Cost-Effective in South Africa?
por: Braithwaite, R. Scott, et al.
Publicado: (2006)

Meeting the Challenge of Influenza Pandemic Preparedness in Developing Countries
por: Fedson, David S.
Publicado: (2009)

How to implement medical evidence into practice in developing countries
por: Al-lawama, Manar
Publicado: (2016)

Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
por: Delgado, Maria Fernanda, et al.
Publicado: (2019)

Cross-Sectional Association between Length of Incarceration and Selected Risk Factors for Non-Communicable Chronic Diseases in Two Male Prisons of Mexico City
por: Silverman-Retana, Omar, et al.
Publicado: (2015)

A roadmap to develop dementia research capacity and capability in Pakistan: A model for low- and middle-income countries
por: Leroi, Iracema, et al.
Publicado: (2019)

Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries
por: Oshitani, Hitoshi, et al.
Publicado: (2008)

Affordable clean energy transition in developing countries: Pathways and technologies
por: Babayomi, Oluleke O., et al.
Publicado: (2022)

Biomedical and societal impacts of in vitro embryo models of mammalian development
por: Moris, Naomi, et al.
Publicado: (2021)

The Role of Social Capital in Successful Adherence to Antiretroviral Therapy in Africa
por: Binagwaho, Agnes, et al.
Publicado: (2009)

The science of rapid start—From the when to the how of antiretroviral initiation
por: Geng, Elvin H., et al.
Publicado: (2017)

Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience
por: So, Anthony D, et al.
Publicado: (2008)

Computational Biology in Cuba: An Opportunity to Promote Science in a Developing Country
por: Pons, Tirso, et al.
Publicado: (2007)

COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022)

Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?
por: Adepoju, Victor Abiola, et al.
Publicado: (2022)

What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?
por: Kenyon, Chris, et al.
Publicado: (2012)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants
por: Mofenson, Lynne M., et al.
Publicado: (2014)

Tobacco supply and demand strategies used in African countries
por: Crosbie, Eric, et al.
Publicado: (2021)

Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries
por: de Kraker, Marlieke E. A.
Publicado: (2023)

Convergence of Mortality Rates among Patients on Antiretroviral Therapy in South Africa and North America
por: Binagwaho, Agnes, et al.
Publicado: (2014)

Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy
por: Suthar, Amitabh B., et al.
Publicado: (2017)

HIV Infection-Associated Frailty: The Solution for Now Is Antiretroviral Drugs: A Perspective
por: Klotz, Stephen A., et al.
Publicado: (2019)

Neglected paths of transmission of milkborne brucellosis and tuberculosis in developing countries: novel control opportunities
por: Milton, Arockiasamy Arun Prince, et al.
Publicado: (2020)

Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
por: Cherian, Neil, et al.
Publicado: (2023)

COVID-19 in the least developed, fragile, and conflict-affected countries — How can the most vulnerable be protected?
por: Ebrahim, Shahul H., et al.
Publicado: (2021)

Model‐Informed Assessment of Anti‐Infectives for Young Children in Low‐ and Middle‐Income Countries
por: Zhao, Ping, et al.
Publicado: (2019)

The Italian Experience in the Development of Mesothelioma Registries: A Pathway for Other Countries to Address the Negative Legacy of Asbestos
por: Magnani, Corrado, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rfqdta3fpoemnjelg8edl2vta1